| 1 |
32338102 | The role of serum osteoprotegerin level in diagnosis of disease and determining cardiovascular risk of polycystic ovary syndrome. | 2020 Nov |
1 |
| 2 |
26311162 | Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. | 2015 Aug 28 |
1 |
| 3 |
22918704 | Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. | 2013 Apr |
4 |
| 4 |
23211475 | Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. | 2013 Jul-Aug |
2 |
| 5 |
21903971 | Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. | 2012 Jul-Aug |
2 |
| 6 |
20974706 | Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. | 2011 Jan |
1 |
| 7 |
22100799 | Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. | 2011 Oct 11 |
1 |
| 8 |
18252198 | 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7. | 2008 Apr 11 |
2 |
| 9 |
12086350 | Correlates of osteoprotegerin levels in women and men. | 2002 May |
1 |
| 10 |
12153751 | Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. | 2002 Aug |
1 |